Uncategorized
Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
Now Eli Lilly has an obesity pill, too.
On Wednesday, the FDA approved orforglipron, the agency announced. It will be sold as Foundayo, and Lilly has previously said it plans to … Read More